3/22
01:17 pm
tmdx
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push [Yahoo! Finance]
Medium
Report
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push [Yahoo! Finance]
3/20
08:52 am
tmdx
Organ Preservation Market Size to Reach USD 547.41 Million by 2035; Rising Transplant Procedures and Advances in Preservation Technologies Driving Market Growth – SNS Insider [Yahoo! Finance]
Low
Report
Organ Preservation Market Size to Reach USD 547.41 Million by 2035; Rising Transplant Procedures and Advances in Preservation Technologies Driving Market Growth – SNS Insider [Yahoo! Finance]
3/16
12:08 pm
tmdx
TransMedics Group (TMDX) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
TransMedics Group (TMDX) had its "buy" rating reaffirmed by TD Cowen.
3/15
09:23 pm
tmdx
Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? [Yahoo! Finance]
3/11
06:05 pm
tmdx
Analysts Raise TransMedics Group, Inc. (TMDX) Price Targets After Q4 Results [Yahoo! Finance]
Medium
Report
Analysts Raise TransMedics Group, Inc. (TMDX) Price Targets After Q4 Results [Yahoo! Finance]
3/9
09:03 am
tmdx
TransMedics Group (TMDX) had its price target raised by Stifel Nicolaus from $115.00 to $130.00. They now have a "hold" rating on the stock.
Medium
Report
TransMedics Group (TMDX) had its price target raised by Stifel Nicolaus from $115.00 to $130.00. They now have a "hold" rating on the stock.
3/8
05:48 am
tmdx
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? [Yahoo! Finance]
Medium
Report
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? [Yahoo! Finance]
2/28
01:00 pm
tmdx
Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]
Medium
Report
Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]
2/27
07:26 am
tmdx
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]
Medium
Report
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]
2/27
07:00 am
tmdx
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
Medium
Report
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
2/26
12:35 pm
tmdx
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]
2/25
01:03 pm
tmdx
TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
12:58 pm
tmdx
TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
Low
Report
TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.
2/25
12:58 pm
tmdx
TransMedics Group (TMDX) had its price target raised by JPMorgan Chase & Co. from $114.00 to $149.00. They now have a "neutral" rating on the stock.
Low
Report
TransMedics Group (TMDX) had its price target raised by JPMorgan Chase & Co. from $114.00 to $149.00. They now have a "neutral" rating on the stock.
2/25
10:24 am
tmdx
TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
Medium
Report
TransMedics Group (TMDX) had its price target raised by Piper Sandler from $140.00 to $160.00. They now have an "overweight" rating on the stock.
2/25
08:03 am
tmdx
TransMedics Group (TMDX) had its price target raised by Needham & Company LLC from $166.00 to $174.00. They now have a "buy" rating on the stock.
High
Report
TransMedics Group (TMDX) had its price target raised by Needham & Company LLC from $166.00 to $174.00. They now have a "buy" rating on the stock.
2/25
12:27 am
tmdx
TransMedics Group Inc (TMDX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
High
Report
TransMedics Group Inc (TMDX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
2/24
04:05 pm
tmdx
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
2/20
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2/17
04:05 pm
tmdx
TransMedics to Present at Upcoming March Investor Conferences
Low
Report
TransMedics to Present at Upcoming March Investor Conferences
2/14
01:32 am
tmdx
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
Medium
Report
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
2/10
04:05 pm
tmdx
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Medium
Report
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
2/9
08:00 am
tmdx
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
Low
Report
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
2/3
09:43 pm
tmdx
TransMedics Group, Inc. (TMDX): A Bull Case Theory [Yahoo! Finance]
Medium
Report
TransMedics Group, Inc. (TMDX): A Bull Case Theory [Yahoo! Finance]
2/3
07:20 am
tmdx
TransMedics: Italian NOP Program Reinforces Huge International Opportunity [Seeking Alpha]
Low
Report
TransMedics: Italian NOP Program Reinforces Huge International Opportunity [Seeking Alpha]